About Marc Lippman
Form D filings for Radiance Biopharma in 2024 list Marc Lippman as executive officer and director.
Marc Lippman first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Marc Lippman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Marc Lippman works with at each company, as listed on that company's latest Form D.
Radiance Biopharma, Inc. · Form D, Feb 28, 2024
RB
Robert Brooks
Chief Executive Officer and director